| Aspect | AVIS (vendor website) | Rayen (Rayen Salud) | InterSystems TrakCare |
|--------|-----------------------|---------------------|------------------------|
| Starting Price | Not publicly listed | Not publicly listed | Not publicly listed |
| Recommended Use Case | Chile/LATAM ambulatory & APS-focused workflows needing EHR + operations modules (agenda, pharmacy, programs) | Chile APS and broader public-sector health ecosystem; documents ISO/IEC 27001:2022 certification | Large/complex health systems needing enterprise EHR platform and interoperability at scale |
| Key Strength | APS-oriented modules; long presence in Chile public networks; vendor states HL7/FHIR support and multiple modules | Documents ISO/IEC 27001:2022 certification; large installed base claims; active communications about interoperability/AI | Global deployments; interoperability capabilities; broad enterprise capability |
| Key Weakness | Limited public security/compliance documentation; limited credible third-party reviews; brand-name ambiguity | Pricing opacity; vendor marketing claims may not be independently verified; can still face public-sector implementation friction | Higher cost and complexity; typically enterprise procurement cycles and heavier implementation |
- Direct competitors and differentiators
- Rayen Salud is a central competitor in Chile’s APS EHR market; it documents ISO/IEC 27001:2022 certification and discusses interoperability.
- InterSystems TrakCare competes more at the hospital/health system enterprise layer; AVIS may integrate with it but can also be considered in overlapping procurements.
- OpenEMR competes on cost (no license fee; open-source) but requires significant local IT capacity and governance; for public-sector networks, the operational burden can be substantial.
- Pricing comparison (value proposition vs alternatives)
- AVIS: 12-month license is mentioned; pricing is opaque.
- Rayen: pricing not easily available; often sold via public tenders.
- TrakCare: no public pricing plans listed and no free trial is advertised in public materials.
- OpenEMR: no license fee; TCO typically driven by hosting, customization, security, and support.
- Customer testimonials comparing AVIS to competitors
- The Hospital Digital forum post provides a tender context comparing bids (AVIS vs Rayen vs others), but not user-experience comparisons post go-live.
- Market share and adoption trends
- AVIS appears present in Chile’s public networks with multiple service-level customers.
- Rayen claims broad national coverage and markets itself as widely used in Chile.
- No rigorous market-share study was found in accessible sources.